Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Swiss Exchange  >  Roche Holding Ltd.    ROG   CH0012032048

ROCHE HOLDING LTD. (ROG)

286
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Swiss Exchange
06/29/2015 06/30/2015 07/01/2015 07/02/2015 07/03/2015 Date
263.4(c) 262(c) 266.3(c) 266.4(c) 265.1(c) Last
1 806 048 2 355 563 1 693 513 1 045 192 902 204 Volume
-1.94% -0.53% +1.64% +0.04% -0.49% Change
More quotes
Financials ( CHF)
Sales 2015 48 168 M
EBIT 2015 17 119 M
Net income 2015 11 403 M
Debt 2015 10 264 M
Yield 2015 3,15%
Sales 2016 50 294 M
EBIT 2016 18 299 M
Net income 2016 12 519 M
Debt 2016 5 950 M
Yield 2016 3,35%
PER 2015 19,52
PER 2016 17,81
EV / Sales 2015 4,93x
EV / Sales 2016 4,64x
Capitalization 227 289 M
More Financials
Company
Roche Holding AG operates as a research-focused healthcare company with combined focus in pharmaceuticals and diagnostics.It operates business through two divisons: Pharmaceuticals and Diagnostics.The Pharmaceuticals divison comprises the two business segments Roche Pharmaceuticals and Chugai,... 
Sector
Pharmaceuticals
Calendar
07/23Earnings Release
More about the company
Surperformance© ratings of Roche Holding Ltd.
Trading Rating : Investor Rating :
More Ratings
Latest news on ROCHE HOLDING LTD.
07/03 Exclusive - Hospira wins French biosimilar drug tender at 45 percent discount
06/30 U.S. seeks up to $3.35 billion in Novartis kickback lawsuit
06/30DJROCHE : Announces Positive Results From Studies on Multiple Sclerosis Drug
06/30 ROCHE : Genentech :’s ocrelizumab Significantly Reduced Both Relapses and ..
06/29 Drugmakers warn Greek medicine supply 'may be in jeopardy'
06/19DJNOVARTIS CEO : Roche Stake Would No Longer Have to Be Sold at Premium
06/16 Energy and medicine top import risk list as Greece teeters
06/11 ROCHE : Ariosa receives CE mark for its FORTE Software to support Harmony™..
More news
Sector news : Pharmaceuticals - NEC
07/03 Exclusive - Hospira wins French biosimilar drug tender at 45 percent discount
07/03 MALLINCKRODT : takes on FDA in fight over ADHD generic
07/03 KYOWA HAKKO KIRIN : Approval for ACOALAN in Japan
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
07/02 FDA clears upstart Theranos' test system
07/02 SEEKING ALPHA'S BIOTECH WEEKLY : Celgene-Juno, Gilead's HIV NDA, Happy 4th!
07/02 Is Avalanche Biotechnologies A Good Buy Now After Phase 2 Results For Its Wet..
07/01 FDA extends PDUFA date for review of cobimetinib NDA; Exelixis off 8%
06/30 THE ISHARES MSCI SWITZERLAND CAPPED : A Fund Worth Yodeling About


Comments 
Advertisement
Chart ROCHE HOLDING LTD.
Duration : Period :
Roche Holding Ltd. Technical Analysis Chart | ROG | CH0012032048 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions